193 related articles for article (PubMed ID: 28905241)
1. Photostability Issues in Pharmaceutical Dosage Forms and Photostabilization.
Janga KY; King T; Ji N; Sarabu S; Shadambikar G; Sawant S; Xu P; Repka MA; Murthy SN
AAPS PharmSciTech; 2018 Jan; 19(1):48-59. PubMed ID: 28905241
[TBL] [Abstract][Full Text] [Related]
2. Assessing impact of manufacturing and package configurations to photosensitive compounds.
Carvalho TC; Escotet ML; Lin J; Sprockel OL
Drug Dev Ind Pharm; 2016; 42(6):936-44. PubMed ID: 26460067
[TBL] [Abstract][Full Text] [Related]
3. Light-sensitive drugs in topical formulations: stability indicating methods and photostabilization strategies.
Ioele G; Tavano L; Luca M; Muzzalupo R; Mancuso A; Ragno G
Future Med Chem; 2017 Oct; 9(15):1795-1808. PubMed ID: 28925725
[TBL] [Abstract][Full Text] [Related]
4. Implications of In-Use Photostability: Proposed Guidance for Photostability Testing and Labeling to Support the Administration of Photosensitive Pharmaceutical Products, Part 3. Oral Drug Products.
Allain L; Baertschi SW; Clapham D; Foti C; Lantaff WM; Reed RA; Templeton AC; Tønnesen HH
J Pharm Sci; 2016 May; 105(5):1586-1594. PubMed ID: 27056630
[TBL] [Abstract][Full Text] [Related]
5. Implications of in-use photostability: proposed guidance for photostability testing and labeling to support the administration of photosensitive pharmaceutical products, part 1: drug products administered by injection.
Baertschi SW; Clapham D; Foti C; Jansen PJ; Kristensen S; Reed RA; Templeton AC; Tønnesen HH
J Pharm Sci; 2013 Nov; 102(11):3888-99. PubMed ID: 24009146
[TBL] [Abstract][Full Text] [Related]
6. A study of photostability and compatibility of the anti-chagas drug Benznidazole with pharmaceutics excipients.
Santos FL; Rolim LA; Figueirêdo CB; Lyra MA; Peixoto MS; Ferraz LR; Soares-Sobrinho JL; Neves de Lima ÁA; Lima Leite AC; Rolim Neto PJ
Drug Dev Ind Pharm; 2015 Jan; 41(1):63-9. PubMed ID: 24134564
[TBL] [Abstract][Full Text] [Related]
7. Implications of In-Use Photostability: Proposed Guidance for Photostability Testing and Labeling to Support the Administration of Photosensitive Pharmaceutical Products, Part 2: Topical Drug Product.
Baertschi SW; Clapham D; Foti C; Kleinman MH; Kristensen S; Reed RA; Templeton AC; Tønnesen HH
J Pharm Sci; 2015 Sep; 104(9):2688-701. PubMed ID: 25711373
[TBL] [Abstract][Full Text] [Related]
8. In-Use Photostability Practice and Regulatory Evaluation for Pharmaceutical Products in an Age of Light-Emitting Diode Light Sources.
Allain LR; Pierce BC; Wuelfing WP; Templeton AC; Helmy R
J Pharm Sci; 2019 Mar; 108(3):1172-1176. PubMed ID: 30315811
[TBL] [Abstract][Full Text] [Related]
9. Gamma sterilization of pharmaceuticals--a review of the irradiation of excipients, active pharmaceutical ingredients, and final drug product formulations.
Hasanain F; Guenther K; Mullett WM; Craven E
PDA J Pharm Sci Technol; 2014; 68(2):113-37. PubMed ID: 24668600
[TBL] [Abstract][Full Text] [Related]
10. The difficulties for a photolabile drug in topical formulations: the case of diclofenac.
Ioele G; De Luca M; Tavano L; Ragno G
Int J Pharm; 2014 Apr; 465(1-2):284-90. PubMed ID: 24491531
[TBL] [Abstract][Full Text] [Related]
11. Implementation of a mathematical model for the photochemical kinetics of a solid form active pharmaceutical ingredient.
La Cruz TE; Carvalho TC; Ramírez A; Tábora JE
Int J Pharm; 2019 Jul; 566():500-512. PubMed ID: 31129341
[TBL] [Abstract][Full Text] [Related]
12. Photostabilization strategies of photosensitive drugs.
Coelho L; Almeida IF; Sousa Lobo JM; Sousa E Silva JP
Int J Pharm; 2018 Apr; 541(1-2):19-25. PubMed ID: 29438725
[TBL] [Abstract][Full Text] [Related]
13. A photochemical kinetic model for solid dosage forms.
Carvalho TC; La Cruz TE; Tábora JE
Eur J Pharm Biopharm; 2017 Nov; 120():63-72. PubMed ID: 28834735
[TBL] [Abstract][Full Text] [Related]
14. Predicting the photostability characteristics of active pharmaceutical ingredients using electron paramagnetic resonance spectroscopy.
Williams HE; Claybourn M
Drug Dev Ind Pharm; 2012 Feb; 38(2):200-8. PubMed ID: 21806507
[TBL] [Abstract][Full Text] [Related]
15. UVA is the major contributor to the photodegradation of tretinoin and isotretinoin: Implications for development of improved pharmaceutical formulations.
Tashtoush BM; Jacobson EL; Jacobson MK
Int J Pharm; 2008 Mar; 352(1-2):123-8. PubMed ID: 18093761
[TBL] [Abstract][Full Text] [Related]
16. [The photostability of antimycotics. 3. Photostability of locally acting antimycotics].
Thoma K; Kübler N; Reimann E
Pharmazie; 1997 May; 52(5):362-73. PubMed ID: 9229718
[TBL] [Abstract][Full Text] [Related]
17. Development of a stability-indicating LC method for determination of a synthetic chalcone derivative in a nanoemulsion dosage form and identification of the main photodegradation product by LC-MS.
Mattos CB; Deponti VB; Barreto F; Simões CM; Andrighetti-Frohner CR; Nunes RJ; Steindel M; Teixeira HF; Koester LS
J Pharm Biomed Anal; 2012 Nov; 70():652-6. PubMed ID: 22884784
[TBL] [Abstract][Full Text] [Related]
18. Photodegradation of fleroxacin injection: II. Kinetics and toxicological evaluation.
Li W; Wang J; Hu YZ
AAPS PharmSciTech; 2013 Jun; 14(2):578-84. PubMed ID: 23463261
[TBL] [Abstract][Full Text] [Related]
19. Photostability of Topical Agents Applied to the Skin: A Review.
Kryczyk-Poprawa A; Kwiecień A; Opoka W
Pharmaceutics; 2019 Dec; 12(1):. PubMed ID: 31861803
[TBL] [Abstract][Full Text] [Related]
20. Excipient variability and its impact on dosage form functionality.
Dave VS; Saoji SD; Raut NA; Haware RV
J Pharm Sci; 2015 Mar; 104(3):906-15. PubMed ID: 25561249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
